ERBB2 and ductal breast carcinoma in situ: DIDS analysis on DCIS-MIND samples identified previously mentioned genes such as high expression of ERBB2 in DCIS with invasive progression or high expression of ESR1 in non-invasive DCIS (Figure 4E; Table S5).